Chronic Kidney Disease in Tasmania: Protocol for a Data Linkage Study (Preprint)
Preprint
- 12 May 2020
- preprint
- Published by JMIR Publications Inc. in JMIR Preprints
Abstract
BACKGROUND Chronic kidney disease (CKD) is a significant and growing health burden globally. Tasmania has the highest state prevalence for non-Indigenous Australians and it has consistently had the lowest incidence and prevalence of dialysis in Australia. OBJECTIVE To examine the gap between the high community prevalence of CKD in Tasmania and the low use of dialysis. METHODS This is a retrospective cohort study using linked data from 5 health and 2 pathology data sets from the island state of Tasmania, Australia. The study population consists of any person (all ages including children) who had a blood measurement of creatinine with the included pathology providers between January 1, 2004, and December 31, 2017. This study population (N=460,737) includes within it a CKD cohort, which was detected via pathology or documentation of kidney replacement therapy (KRT; dialysis or kidney transplant). Kidney function (estimated glomerular filtration rate [eGFR]) was calculated using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) formula. Individuals with 2 measures of eGFR<60 mL/min/1.73 m2, at least 90 days apart, were identified as having CKD and were included in the CKD cohort. Individuals treated with dialysis or transplant were identified from the Australia and New Zealand Dialysis and Transplant Registry. RESULTS The study population consisted of 460,737 people (n=245,573 [53.30%] female, mean age 47.4 years) who were Tasmanian residents aged 18 years and older and were followed for a median of 7.8 years. During the later 5 years of the study period, 86.79% (355,622/409,729) of Tasmanian adults were represented. The CKD cohort consisted of 56,438 people (ie, 12.25% of the study population; 53.87% (30,405/56,438) female, mean age 69.9 years) followed for a median of 10.4 years with 56,039 detected via eGFR and 399 people detected via documentation of KRT. Approximately half (227,433/460,737, 49.36%) of the study population and the majority of the CKD cohort (41,448/56,438, 73.44%) had an admission episode. Of the 55,366 deaths recorded in the study population, 45.10% (24,970/55,366) had CKD. CONCLUSIONS Whole-of-population approaches to examine CKD in the community can be achieved by data linkage. Over this 14-year period, CKD affected 12.25% (56,438/460,737) of Tasmanian adult residents and was present in 45.10% (24,970/55,366) of deaths. INTERNATIONAL REGISTERED REPORT DERR1-10.2196/20160Keywords
All Related Versions
- Published version: JMIR Research Protocols, 9 (9), e20160.
This publication has 10 references indexed in Scilit:
- Table 3: Diagnostic results (positive or negative) from blood β-hydroxybutyrate (BHB) concentration measured by handheld meter and gold-standard colorimetric method indicative of moderate ketosis (BHB 0.8–1.6 mmol/L) or for severe ketosis (BHB ≥ 1.6 mmol/L).2020
- Advances in Chronic Kidney Disease as SyntopiconAdvances in Chronic Kidney Disease, 2019
- CKD: A Call for an Age-Adapted DefinitionJournal of the American Society of Nephrology, 2019
- Chronic Kidney Disease in the Kidney Transplant Recipient2019
- Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016The Lancet, 2017
- Cost to government and society of chronic kidney disease stage 1–5: a national cohort studyInternal Medicine Journal, 2015
- Remembering the forgotten non-communicable diseasesBMC Medicine, 2014
- Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: new developments and revised recommendationsMedical Journal of Australia, 2012
- Heart Failure in the Fetus with Congenital Heart Disease2010
- Chronic kidney disease in TasmaniaNephrology, 2009